5-(3-pyridyl)tetrazole, a potent and long-acting lipolysis inhibitor.
作者信息
Holland G F, Pereira J N
出版信息
Experientia. 1967 Feb 15;23(2):88-9. doi: 10.1007/BF02135931.
PMID:6040484
Abstract
摘要
相似文献
1
5-(3-pyridyl)tetrazole, a potent and long-acting lipolysis inhibitor.5-（3-吡啶基）四唑，一种强效长效的脂肪分解抑制剂。
Experientia. 1967 Feb 15;23(2):88-9. doi: 10.1007/BF02135931.
2
The effect of nicotinamide adenine dinucleotide on lipolysis in adipose tissue in vitro.烟酰胺腺嘌呤二核苷酸对体外脂肪组织脂解作用的影响。
Experientia. 1966 Oct 15;22(10):658-9. doi: 10.1007/BF01902426.
3
The pharmacology of 5-(3-pyridyl)tetrazole, a hypocholesteremic lipolysis inhibitor.5-（3-吡啶基）四唑的药理学，一种降胆固醇的脂肪分解抑制剂。
J Pharmacol Exp Ther. 1968 Jul;162(1):148-54.
4
Alteration in liver lipid and lipid fatty acid composition after partial hepatectomy in the rat.大鼠部分肝切除术后肝脏脂质及脂质脂肪酸组成的变化
Exp Mol Pathol. 1968 Apr;8(2):190-200. doi: 10.1016/0014-4800(68)90015-4.
5
The development of resistance to a potent lipolysis inhibitor, 3-methylisoxazole-5-carboxylic acid.对一种强效脂肪分解抑制剂3-甲基异恶唑-5-羧酸的抗性发展
J Pharmacol Exp Ther. 1967 Aug;157(2):381-7.
6
Heterocyclic tetrazoles, a new class of lipolysis inhibitors.杂环四唑，一类新型的脂肪分解抑制剂。
J Med Chem. 1967 Mar;10(2):149-54. doi: 10.1021/jm00314a004.
7
8
Potential antilipolytic activity of suloctidil.舒洛地尔的潜在抗脂解活性。
Naturwissenschaften. 1975 Mar;62(3):141-2. doi: 10.1007/BF00623284.
9
Lowering of blood ketone bodies induced by drugs preventing free fatty acid mobilization.通过阻止游离脂肪酸动员的药物诱导血酮体降低。
Experientia. 1966 Oct 15;22(10):664. doi: 10.1007/BF01902430.
10
Some aspects of fatty acid metabolism in brown adipose tissue.棕色脂肪组织中脂肪酸代谢的某些方面。
Lipids. 1970 Feb;5(2):220-3. doi: 10.1007/BF02532472.
本文引用的文献
1
PERSISTENCE OF THE INHIBITORY EFFECT OF NICOTINIC ACID ON CATECHOLAMINE-STIMULATED LIPID MOBILIZATION DURING PROLONGED TREATMENT WITH NICOTINIC ACID.烟酸长期治疗期间，烟酸对儿茶酚胺刺激的脂质动员的抑制作用的持续性。
J Atheroscler Res. 1965 Jul-Aug;5(4):436-9. doi: 10.1016/s0368-1319(65)80080-1.
2
Studies on the effect of nicotinic acid on catecholamine stimulated lipolysis in adipose tissue in vitro.烟酸对体外脂肪组织中儿茶酚胺刺激的脂肪分解作用的研究。
Acta Med Scand. 1963 Jun;173:719-22. doi: 10.1111/j.0954-6820.1963.tb17457.x.
3
The effect of nicotinic acid on the plasma free fatty acid; demonstration of a metabolic type of sympathicolysis.烟酸对血浆游离脂肪酸的作用；一种代谢性交感神经阻滞类型的证明。
Acta Med Scand. 1962 Dec;172:641-5. doi: 10.1111/j.0954-6820.1962.tb07203.x.
4
3-Pyridineacetic acid and nicotinic acid: blood levels, urinary elimination and excretion of nicotinic acid derivatives in man.3-吡啶乙酸与烟酸：人体中烟酸衍生物的血药浓度、尿排泄及排泄情况
Nature. 1962 Mar 10;193:948-9. doi: 10.1038/193948a0.
5
The fate and excretion of C14-labeled pentylenetetrazol in the rat, with comments on analytical methods for pentylenetetrazol.大鼠体内C14标记的戊四氮的命运与排泄，并对戊四氮的分析方法加以评论
J Pharmacol Exp Ther. 1956 Oct;118(2):129-38.
6
A relation between non-esterified fatty acids in plasma and the metabolism of glucose.血浆中非酯化脂肪酸与葡萄糖代谢之间的关系。
J Clin Invest. 1956 Feb;35(2):150-4. doi: 10.1172/JCI103259.
Zotero 插件